Clinical Development & Data
Trial architecture, endpoints, recruitment, comparator signals, investigator interpretation, and the way evidence in medical devices will be read downstream.
Medical Devices
ICG works across medical-device environments where technical configuration, clinical workflow, human factors, regulatory pathways, purchasing systems, and adoption behavior interact.
The work includes medical-device competitive intelligence, drug-delivery and connected systems, injectors and inhalers, diagnostics and biomarkers, combination products, clinical workflow, procurement, launch, and market development.
The Device Exists Inside an Operating System.
A device may be technically differentiated yet constrained by workflow, training, evidence, reimbursement, installed practice, purchasing, interoperability, or the therapy with which it is used.
ICG reconstructs those dependencies across user, company, clinical, regulatory, and commercial environments to identify what will govern adoption and displacement.
Decision Environments
Engagements begin at different points, but the governing constraints often cross the boundaries of the initial request.
Regulatory & Access Pathways
Filing logic, label conditions, evidence requirements, reimbursement, pathway position, and country-level adoption constraints.
Launch & Commercial Architecture
Market preparation, field-force and medical roles, account coverage, channel structure, patient support, and launch sequencing.
Manufacturing & Delivery
Capacity, supply, configuration, administration, device or site readiness, and the relationship between operational uncertainty and asset value.
Patient & Treatment Systems
Patient identification, referral patterns, specialist pathways, administration burden, monitoring, persistence, and continuity of treatment.
Longitudinal Competitive Monitoring
Clinical, regulatory, access, organization, and commercial signals reconstructed across multi-phase and multi-year programs.
Evidence Architecture
The evidence base is developed through source calls and interviews positioned close to the decisions, constraints, and operating conditions being reconstructed.
Clinical & Investigator Side
Key opinion leaders, principal investigators, study-site personnel, treating specialists, centers of excellence, diagnostic pathways, and investigator-side clinical teams.
Company-Side Sources
Clinical development, regulatory, medical affairs, CMC and manufacturing, market access, patient services, field leadership, commercial, and portfolio functions.
Access & Operating Systems
Payer and reimbursement environments, procurement, distribution, treatment centers, testing providers, administration systems, patient-support infrastructure, and local access pathways.
Triangulation
Interview evidence is tested against clinical, regulatory, manufacturing, access, and organizational signals and against the criteria used by reviewers, payers, clinicians, partners, and other decision-makers.
Selected Project Record
Selected engagements across medical devices.
The projects below are selected from a substantially larger body of work. They were chosen to illustrate different decision environments, lifecycle stages, modalities, geographies, and forms of engagement. The selection is illustrative rather than exhaustive. Multi-phase and longitudinal assignments may be presented as a single project title, and company, asset, or market details may be generalized where appropriate.
Drug Delivery & Connected Systems
- Digital-Inhaler and Connected Respiratory-Device Landscape
- Device Strategy and Launch Assessment for High-Dose Auto-Injectors in Immunology
- Global Epinephrine Auto-Injector and Delivery-Device Landscape
- Home-Administration Device Landscape for Crohn's Disease
Diagnostics & Biomarkers
- Companion-Diagnostic and Biomarker Architecture for PARP Inhibitors in Oncology
- Diagnostic and Biomarker Strategy for PD-L1 Oncology Assays
- Molecular and Respiratory Diagnostics Market Monitoring
- Longitudinal Diagnostic-Pathway Monitoring in Oncology
Integration, Launch & Monitoring
- Device, Manufacturing and Partner Landscape for Hemophilia Gene Therapy
- Prefilled-Syringe and Packaging Architecture for a Leading Retinal Therapy
- Continuous-Glucose-Monitoring and Sensor Landscape
- Oncology Assay Adoption and Clinical-Workflow Architecture
Medical Devices Engagements
ICG can enter at the level of a single critical question, a multi-market evidence program, or a longitudinal clinical, regulatory, manufacturing, access, commercial, or operating-system decision environment.